Your browser doesn't support javascript.
loading
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.
Wee, Zhen Ning; Yatim, Siti Maryam J M; Kohlbauer, Vera K; Feng, Min; Goh, Jian Yuan; Bao, Yi; Yi, Bao; Lee, Puay Leng; Zhang, Songjing; Wang, Pan Pan; Lim, Elgene; Tam, Wai Leong; Cai, Yu; Ditzel, Henrik J; Hoon, Dave S B; Tan, Ern Yu; Yu, Qiang.
  • Wee ZN; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Yatim SM; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Kohlbauer VK; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Feng M; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Goh JY; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Bao Y; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Yi B; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Lee PL; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Zhang S; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Wang PP; First Affiliated Hospital, Jinan University, Guangzhou 510632, China.
  • Lim E; Cancer Research Institute, Jinan University, Guangzhou 510632, China.
  • Tam WL; The Kinghorn Cancer Center, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Cai Y; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, A*STAR (Agency for Science, Technology and Research), 60 Biopolis Street, 02-01, Biopolis 138672, Singapore.
  • Ditzel HJ; Cancer Science Institute, National University of Singapore, Singapore 117599, Singapore.
  • Hoon DS; Cancer Research Institute, Jinan University, Guangzhou 510632, China.
  • Tan EY; School of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Yu Q; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense 5000, Denmark.
Nat Commun ; 6: 8746, 2015 Oct 27.
Article en En | MEDLINE | ID: mdl-26503059
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Paclitaxel / Quinasas Asociadas a Receptores de Interleucina-1 / Antineoplásicos Fitogénicos Límite: Animals / Female / Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Paclitaxel / Quinasas Asociadas a Receptores de Interleucina-1 / Antineoplásicos Fitogénicos Límite: Animals / Female / Humans Idioma: En Año: 2015 Tipo del documento: Article